Percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal calculi. Papillary puncture is the mainstay of treatment for large renal calculi, but the non-papillary has been introduced and gained some interest. The aim of this study is the investigation of trends of non-papillary access for PCNL over the years. A review of the literature took place and 13 publications were included in the study. Two experimental studies investigating the feasibility of non-papillary access were found. Five cohort prospective and 2 retrospective studies for non-papillary access and 4 comparative studies between papillary and non-papillary access were included. Non papillary access is a technique that has been proved as a safe and efficient solution that keeps up with the latest endoscopic trends. A wider use of this method could be expected in the future.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.acuroe.2023.06.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical Characteristics and Treatment Outcomes of Thyroid Cancer at a Tertiary Care Hospital in Najran Region, Saudi Arabia: A Single-Centre Retrospective Study.
Cureus
October 2024
Internal Medicine, Yale New Haven Health, Bridgeport Hospital, Bridgeport, USA.
Article Synopsis
- The study examined thyroid cancer cases at a hospital in Najran, Saudi Arabia, involving 279 patients from 2014 to 2021, primarily affecting women with a mean age of 42.8 years.
- Most patients (60.9%) underwent total thyroidectomy, with a significant number showing localized disease; papillary and follicular cancers were the most common types.
- Independent factors influencing mortality included older age, diabetes, certain cancer subtypes, and metastatic disease, with particularly high risks associated with tumor size and pulmonary metastasis.
Relevance of the Immunohistochemical Expression of p53 and E-cadherin in the Grading of Urothelial Carcinoma: A Single-Center Cross-Sectional Observational Study.
Cureus
October 2024
Department of Surgery, Maharani Laxmi Bai Medical College, Jhansi, IND.
Article Synopsis
- * The study examined the expression of p53 and E-cadherin in a group of 50 confirmed UC cases, using immunohistochemical methods to identify correlations with tumor grade and clinicopathological features.
- * Results showed that high-grade UC was prevalent and associated with low E-cadherin expression, indicating a potential relationship between reduced E-cadherin and tumor invasiveness, while elevated p53 was observed in all cases, suggesting its role in cancer progression.
A deep-learning workflow to predict upper tract urothelial carcinoma protein-based subtypes from H&E slides supporting the prioritization of patients for molecular testing.
J Pathol Clin Res
March 2024
Institute of Pathology, University Hospital Erlangen-Nürnberg, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
Article Synopsis
- Upper tract urothelial carcinoma (UTUC) is a rare and aggressive cancer that differs from more common bladder urothelial carcinoma, which has identifiable molecular subtypes and targeted therapies.
- Researchers identified protein-based subtypes of UTUC tumors using deep learning models that analyze routine histopathological slides, allowing for better prediction of tumor characteristics.
- The study found significant links between the predicted subtypes and key tumor features, including shape, histological type, and important biomarkers like PD-L1 and FGFR3 mutations, which could guide future treatment approaches.
Percutaneous nephrolithotomy non-papillary puncture trends. A review of the literature.
Actas Urol Esp (Engl Ed)
January 2024
Servicio de Urología, Hospital Universitario de Rion, Patras, Greece; Hospital Universitario de Viena, Viena, Austria.
Percutaneous nephrolithotomy (PCNL) is the gold standard of treatment for large renal calculi. Papillary puncture is the mainstay of treatment for large renal calculi, but the non-papillary has been introduced and gained some interest. The aim of this study is the investigation of trends of non-papillary access for PCNL over the years.
View Article and Find Full Text PDFComparing the outcomes of papillary and non-papillary access in percutaneous nephrolithotomy.
World J Urol
February 2023
Department of Urology, Zahedan University of Medical Sciences, Zahedan, Iran.
Background: Some publications have recently been released on the safety of non-papillary access (NPA) in percutaneous nephrolithotomy (PCNL) by a Greek group. The purpose of this study was to prospectively examine the outcome of NPA during two years in a referral center.
Methods: This prospective cohort study was conducted on PCNL operations performed from January 2020 to April 2022 in Labbafinejad Hospital.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!